Literature DB >> 7999636

The myocardial effects of fenoterol, isoprenaline and salbutamol in normoxic and hypoxic sheep.

R J Pack1, M R Alley, J A Dallimore, K R Lapwood, C Burgess, J Crane.   

Abstract

Three groups, each of four sheep, were randomly allocated under blinded conditions to receive the beta-adrenoceptor agonists, salbutamol, fenoterol or isoprenaline, in doses of 0.5, 2, 8, 32 and 128 micrograms/kg intravenously at 15-minute intervals. A separate group of four animals received equal volumes of saline. Heart rate was recorded immediately prior to each drug administration and serum potassium was measured. Three to 4 days later the experiment was repeated during induced systemic hypoxia and the animals then necropsied. All the agonists produced significant increases in heart rate. During hypoxia, lower heart rates were recorded than in the normoxic experiments. Under conditions of hypoxia, all the beta-agonists produced significant hypokalaemia. Sterile saline had no effect on either heart rate or serum potassium levels. At necropsy, myocardial lesions were found in animals receiving all three beta-agonists. Subendocardial haemorrhage was consistently seen in all animals receiving fenoterol. Multifocal myonecrosis of 3-4 days duration was present in the left ventricle of all animals receiving fenoterol, in two receiving isoprenaline and in two receiving salbutamol. The lesions were most severe in the papillary muscle and were visible grossly in one animal given fenoterol and one given isoprenaline. No lesions were found in the control animals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7999636      PMCID: PMC2001865     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  18 in total

1.  Myocardial lesions, circulatory and electrocardiographic changes produced by isoproterenol in the dog.

Authors:  G RONA; T ZSOTER; C CHAPPEL; R GAUDRY
Journal:  Rev Can Biol       Date:  1959-04

2.  Severe myocardial necrosis produced by isoproterenol in the rat.

Authors:  C I CHAPPEL; G RONA; T BALAZS; R GAUDRY
Journal:  Arch Int Pharmacodyn Ther       Date:  1959-10-01

3.  An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat.

Authors:  G RONA; C I CHAPPEL; T BALAZS; R GAUDRY
Journal:  AMA Arch Pathol       Date:  1959-04

4.  Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study.

Authors:  K Woodman; N Pearce; R Beasley; C Burgess; J Crane
Journal:  Clin Pharmacol Ther       Date:  1992-05       Impact factor: 6.875

5.  Effect of intravenous infusion of salbutamol on ventilatory response to carbon dioxide and hypoxia and on heart rate and plasma potassium in normal men.

Authors:  A G Leitch; L J Clancy; J F Costello; D C Flenley
Journal:  Br Med J       Date:  1976-02-14

6.  Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.

Authors:  N Pearce; J Grainger; M Atkinson; J Crane; C Burgess; C Culling; H Windom; R Beasley
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

7.  Myocardial contraction band lesions in patients with fatal asthma: possible neurocardiologic mechanisms.

Authors:  F W Drislane; M A Samuels; H Kozakewich; F J Schoen; R C Strunk
Journal:  Am Rev Respir Dis       Date:  1987-02

8.  The cardio-toxicity of isoprenaline during hypoxia.

Authors:  J M Collins; D G McDevitt; R G Shanks; J G Swanton
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

9.  Cocaine and the heart.

Authors:  H D Tazelaar; S B Karch; B G Stephens; M E Billingham
Journal:  Hum Pathol       Date:  1987-02       Impact factor: 3.466

10.  Human stress cardiomyopathy. Myocardial lesions in victims of homicidal assaults without internal injuries.

Authors:  M S Cebelin; C S Hirsch
Journal:  Hum Pathol       Date:  1980-03       Impact factor: 3.466

View more
  4 in total

Review 1.  Asthma and the beta agonist debate.

Authors:  J Crane; N Pearce; C Burgess; R Beasley
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

2.  Relative myotoxic and haemodynamic effects of the beta-agonists fenoterol and clenbuterol measured in conscious unrestrained rats.

Authors:  Jatin G Burniston; Lip-Bun Tan; David F Goldspink
Journal:  Exp Physiol       Date:  2006-09-14       Impact factor: 2.969

3.  Randomized, double-blind, and placebo-controlled trial of clenbuterol in denervated muscle atrophy.

Authors:  Guang-Liang Jiang; Yu-Dong Gu; Li-Yin Zhang; Li-Ying Shen; Cong Yu; Jian-Guang Xu
Journal:  ISRN Pharm       Date:  2011-08-15

4.  Formoterol in the treatment of experimental cancer cachexia: effects on heart function.

Authors:  Míriam Toledo; Jochen Springer; Sílvia Busquets; Anika Tschirner; Francisco J López-Soriano; Stefan D Anker; Josep M Argilés
Journal:  J Cachexia Sarcopenia Muscle       Date:  2014-08-29       Impact factor: 12.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.